Literature DB >> 29345379

Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection.

Elena Chiricozzi1, Nicoletta Loberto1, Domitilla Schiumarini1, Maura Samarani1, Giulia Mancini1, Anna Tamanini2, Giuseppe Lippi3, Maria Cristina Dechecchi2, Rosaria Bassi1, Paola Giussani1, Massimo Aureli1.   

Abstract

Sphingolipids (SLs) are amphiphilic molecules mainly associated with the external leaflet of eukaryotic plasma membrane, and are structural membrane components with key signaling properties. Since the beginning of the last century, a large number of papers described the involvement of these molecules in several aspects of cell physiology and pathology. Several lines of evidence support the critical role of SLs in inflammatory diseases, by acting as anti- or pro-inflammatory mediators. They are involved in control of leukocyte activation and migration, and are recognized as essential players in host response to pathogenic infection. We propose here a critical overview of current knowledge on involvement of different classes of SLs in inflammation, focusing on the role of simple and complex SLs in pathogen-mediated inflammatory response. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  gangliosides; inflammatory response; plasma membrane; sphingolipids; sphingosine-1-phosphate

Mesh:

Substances:

Year:  2018        PMID: 29345379     DOI: 10.1002/JLB.3MR0717-269R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

Review 1.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

2.  Glycosphingolipids.

Authors:  Elena Chiricozzi; Massimo Aureli; Laura Mauri; Erika Di Biase; Giulia Lunghi; Maria Fazzari; Manuela Valsecchi; Emma Veronica Carsana; Nicoletta Loberto; Alessandro Prinetti; Sandro Sonnino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Host Metabolic Response in Early Lyme Disease.

Authors:  Bryna L Fitzgerald; Claudia R Molins; M Nurul Islam; Barbara Graham; Petronella R Hove; Gary P Wormser; Linden Hu; Laura V Ashton; John T Belisle
Journal:  J Proteome Res       Date:  2020-01-09       Impact factor: 4.466

4.  Pharmaceutical analysis of different antibiotic regimens in the treatment of lower respiratory tract infection.

Authors:  Lin Zhang; Benhong Liu; Chunbin Wang
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

Review 5.  Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Authors:  Sara Grassi; Laura Mauri; Simona Prioni; Livia Cabitta; Sandro Sonnino; Alessandro Prinetti; Paola Giussani
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

6.  Medial calcification in the arterial wall of smooth muscle cell-specific Smpd1 transgenic mice: A ceramide-mediated vasculopathy.

Authors:  Owais M Bhat; Xinxu Yuan; Chad Cain; Fadi N Salloum; Pin-Lan Li
Journal:  J Cell Mol Med       Date:  2019-11-19       Impact factor: 5.310

Review 7.  Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.

Authors:  Ralf A Claus; Markus H Graeler
Journal:  Front Med (Lausanne)       Date:  2021-01-20

Review 8.  Sphingolipids as Modulators of SARS-CoV-2 Infection.

Authors:  Kid Törnquist; Muhammad Yasir Asghar; Vignesh Srinivasan; Laura Korhonen; Dan Lindholm
Journal:  Front Cell Dev Biol       Date:  2021-06-17

Review 9.  Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.

Authors:  Anna Esposito; Daniele D'Alonzo; Maria De Fenza; Eliana De Gregorio; Anna Tamanini; Giuseppe Lippi; Maria Cristina Dechecchi; Annalisa Guaragna
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

Review 10.  Iron and Sphingolipids as Common Players of (Mal)Adaptation to Hypoxia in Pulmonary Diseases.

Authors:  Sara Ottolenghi; Aida Zulueta; Anna Caretti
Journal:  Int J Mol Sci       Date:  2020-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.